Recursion Pharmaceuticals, Inc. (RXRX)
3.54
-0.10
(-2.75%)
USD |
NASDAQ |
Mar 05, 16:00
3.55
+0.01
(+0.28%)
After-Hours: 20:00
Recursion Pharmaceuticals Free Cash Flow : -380.44M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intellia Therapeutics, Inc. | -395.86M |
| Hims & Hers Health, Inc. | 57.42M |
| Novavax, Inc. | -251.02M |
| Geron Corp. | -110.95M |
| XOMA Royalty Corp. | -15.89M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -46.07M |
| Cash from Investing (Quarterly) | -1.244M |
| Cash from Financing (Quarterly) | 132.01M |
| Free Cash Flow Per Share (Quarterly) | -0.0898 |
| Free Cash Flow to Equity (Quarterly) | -42.91M |
| Free Cash Flow to Firm (Quarterly) | -47.32M |
| Free Cash Flow Yield | -23.96% |